Fluconazole

Half-Life (t½)
PO: 34h · IV: 34h
Formula
C13H12F2N6O
Molecular Weight
306.27 g/mol
PubChem CID
3365
Aliases
Diflucan

Pharmacological Mechanism

Triazole antifungal — inhibits Candida / Cryptococcus 14α-demethylase (CYP51) blocking ergosterol synthesis. In humans inhibits CYP2C9, CYP2C19, and CYP3A4 — moderate DDI perpetrator at doses ≥ 200 mg/d (warfarin INR rises predictably). Renally cleared; long t½ allows once-daily dosing.

Half-Life & Elimination Curve (PO: 34h · IV: 34h)

100%50%25%12.5%0%0h0×t½34h1×t½68h2×t½4.3d3×t½5.7d4×t½7.1d5×t½0×t½ (0h): 100% remaining (~3.46 mg/L)1×t½ (34h): 50% remaining (~1.73 mg/L)2×t½ (68h): 25% remaining (~0.865 mg/L)3×t½ (4.3d): 12.5% remaining (~0.433 mg/L)4×t½ (5.7d): 6.3% remaining (~0.216 mg/L)5×t½ (7.1d): 3.1% remaining (~0.108 mg/L)
Plasma (PO)t½ Decay (34h)
  • 0×t½0h100% (3.46 mg/L)
  • 1×t½34h50% (1.73 mg/L)
  • 2×t½68h25% (0.865 mg/L)
  • 3×t½4.3d12.5% (0.433 mg/L)
  • 4×t½5.7d6.3% (0.216 mg/L)
  • 5×t½7.1d3.1% (0.108 mg/L)
Elimination t½34h (PO)
Rate Constant (ke)0.0204 h⁻¹
Time to Peak (Tmax)1.94h
Est. Peak (Cmax)3.46 mg/L
Clearance (CL)1.02 L/h
97% Washout (5×t½)7.1d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References